Synergy CHC Corp.

SNYR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024
Assets
Cash & Equivalents $292.1K $2.6M $1.0M $1.5M $177.9K $687.9K $259.4K $187.3K
Accounts Receivable $1.3M $3.2M $6.8M $7.1M $4.4M $5.3M $4.1M
Inventory $3.4M $3.7M $2.1M $2.4M $2.3M $1.7M $1.9M
Total Current Assets $6.3M $10.0M $20.5M $19.5M $15.4M $16.1M $11.9M
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill) $116.7K $150.0K $183.3K $216.7K $250.0K $283.3K $316.7K
Total Assets $6.5M $10.2M $20.7M $19.7M $15.7M $16.3M $12.2M
Liabilities
Accounts Payable
Total Current Liabilities $6.8M $8.2M $3.8M $7.1M $8.1M $17.2M $18.2M
Long-Term Debt $25.0M $25.1M $25.1M $25.0M $10.9M $7.5M
Total Liabilities $31.9M $33.3M $28.9M $32.1M $31.3M $33.0M $37.3M
Stockholders' Equity
Retained Earnings $-59.0M $-56.4M $-41.6M $-41.8M $-43.2M $-44.1M $-44.3M
Total Stockholders' Equity $-25.4M $-23.1M $-8.3M $-12.4M $-15.6M $-16.6M $-25.2M $-25.9M
← Newer Page 1 of 7 Older →